Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENSP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,255
Award facts
- Contract value 100% obligated
- $4,255.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,255.34 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with a $499.9 billion ceiling value established under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025. The delivery order represents one of multiple purchase actions issued to the contractor to supply pharmaceutical products and medical consumables supporting Department of Defense healthcare operations. No set-aside designation was applied to this award, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to federal military healthcare facilities. The contractor's extensive product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. As a critical supplier within the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning the company as a key regional prime vendor contractor under the broader $30.3 billion PPV-G GEN V acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FENSP?
SPE2DU26FENSP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DU26FENSP worth?
The government has obligated $4,255 on SPE2DU26FENSP.
Is contract SPE2DU26FENSP an order under another contract?
Yes. SPE2DU26FENSP is a delivery order under SPE2DU25D9420, an indefinite delivery contract.
Was contract SPE2DU26FENSP competed?
The extent of competition for SPE2DU26FENSP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award